Resources

Boston Scientific has closed the acquisition of UK-based BTG, which provides products used in minimally-invasive procedures related to cancer and vascular diseases. The companies signed an agreement covering the £3.3bn ($4.2bn) acquisition in November last year....

Royal Philips has introduced the new HeartStart Intrepid monitor/defibrillator to assess and treat patients in medical emergencies across pre-hospital and hospital settings. In hospitals, the device can be used by clinicians to evaluate a patient and provide the...

An international research team led by the University of Edinburgh in the UK will work on the development of new technologies to diagnose tuberculosis (TB). The researchers aim to make the new tests low-cost and easy-to-use even in remote settings. The diagnostic tests...

A new voice assistant that improves internet browsing for people with visual impairments has been developed by researchers at the University of Waterloo in Ontario, Canada. The tool, dubbed Voice Exploration, Retriveal and Search (VERSE), was created in collaboration...

To get a peek into how cells combine to form tissues and how tissues lay the foundations of organs, you can check in at different times using a microscope as they grow—or, you can build the organ itself around a mesh of integrated, electric sensors.

SpringWorks Therapeutics has filed to raise $115 million in an IPO. The money will take SpringWorks through to regulatory filings for two former Pfizer drugs against rare tumors.

Juvenescence has raised $100 million to advance multiple anti-aging programs. The U.K. company, which was co-founded by Jim Mellon, has reeled in $165 million over 18 months to establish itself at the forefront of the nascent longevity sector.

Researchers at Stanford University in the US have developed new sensors that can be adhered to the skin for wireless health monitoring. The sensors are designed to identify the physiological signals that the skin emanates, such as pulse. These readings will be...

While minimally invasive procedures for replacing a heart valve have typically targeted patients considered too risky for open-heart surgery, the FDA now says that younger and potentially more active patients can take that route, too.

The FDA approved the first spinal tether medical device to correct the most common form of scoliosis in children and adolescents—a ropelike implant that pulls the vertebrae into shape as the child grows.

The startup paradigm for the creation and funding of new biotech companies has evolved enormously over the past two decades. Recently there’s been a pair of articles from Tech VCs about applying alternative models of company creation (here, here) to the...

New therapeutic platforms, like those based on cell and gene therapy, provide potential to address diseases in new ways and hold tremendous promise for alleviating human suffering.  Despite this, progress often reaches a critical juncture when attempts are made...

The European Commission (EC) on Tuesday set forth the common specifications (CS) for the reprocessing of single-use medical devices under the EU’s medical device regulation (MDR). The EC is proposing the CS via a draft implementing regulation to specify...

Medline and Greenhealth Exchange (GX), a group purchasing consortium for health systems, today announced a new partnership that will unite manufacturing and clinical expertise to drive innovation and bring green products to the healthcare marketplace. The partnership...

Some of the most promising and innovative research underlying biotech start-ups arises in research institutions.  It is often with those very institutions that we can best collaborate to advance such innovations.   Academic researchers are insightful...

Disarm Therapeutics has a full-time CEO—the neuro-focused biotech has signed on Alvin Shih, M.D., the former Retrophin R&D chief who went on to helm Enzyvant until February this year. Read more. The post Disarm Therapeutics brings on former...

This comprehensive guide details a range of medically focused power solutions including ac-dc and dc-dc products ranging from low to high voltage

Farms are fast emerging as the new frontier for exciting technologies and new applications.

Can nanoparticles prevent overreactions in the immune system and sidestep paralysis?

This small, reliable detector has the performance of lab-based equipment, plus it’s faster.

These vessels also withstand inflating and deflating as blood is pumped through them.

The field of biotechs developing treatments for Duchenne muscular dystrophy became more crowded this week, with biotech startup Dyne setting its sights on the muscle-wasting rare disease. Read more. The post Undeterred by Vertex’s plans, biotech Dyne enters...